| pubmed-article:18657652 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0042523 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0441471 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0332152 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C0439185 | lld:lifeskim |
| pubmed-article:18657652 | lifeskim:mentions | umls-concept:C1512888 | lld:lifeskim |
| pubmed-article:18657652 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:18657652 | pubmed:dateCreated | 2008-7-28 | lld:pubmed |
| pubmed-article:18657652 | pubmed:abstractText | In patients with prior myocardial infarction (MI), beta-blockers reduce mortality by 23% to 40%. However, despite this favorable effect, adverse effects limit compliance to this medication. The purpose of the study was to compare a beta-blocker-based strategy with a heart rate-lowering calcium antagonists-based strategy in patients with prior MI. | lld:pubmed |
| pubmed-article:18657652 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18657652 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18657652 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18657652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18657652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18657652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18657652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18657652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18657652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18657652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18657652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18657652 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18657652 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:18657652 | pubmed:issn | 1097-6744 | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:SleightPeterP | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:ManciaGiusepp... | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:CohenJerome... | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:PepineCarl... | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:MesserliFranz... | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:ZhouQianQ | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:KoweyPeterP | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:INVEST... | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:BangaloreSrip... | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:ChampionAnnet... | lld:pubmed |
| pubmed-article:18657652 | pubmed:author | pubmed-author:BacherPeter... | lld:pubmed |
| pubmed-article:18657652 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18657652 | pubmed:volume | 156 | lld:pubmed |
| pubmed-article:18657652 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18657652 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18657652 | pubmed:pagination | 241-7 | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:meshHeading | pubmed-meshheading:18657652... | lld:pubmed |
| pubmed-article:18657652 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18657652 | pubmed:articleTitle | Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. | lld:pubmed |
| pubmed-article:18657652 | pubmed:affiliation | Division of Cardiovascular Medicine, St. Luke's-Roosevelt Hospital Center, New York, NY 10025, USA. | lld:pubmed |
| pubmed-article:18657652 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18657652 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:18657652 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18657652 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18657652 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18657652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18657652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18657652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18657652 | lld:pubmed |
